TEDD (Tissue Engineering for Drug Development and Substance Testing) is an education, R&D and networking platform promoting the application of 3D organotypic technologies, with the core goal of replacing animal experimentation for therapies development. Based in Switzerland, TEDD is one of its kind in Europe focused on 3D for 3Rs. The community is composed of international members from academia, clinics, industry and non-profits. Training of members is achieved through regular events at the national and international level, including workshops, symposia, company visits, and scientific reviews and we provide a platform to generate research consortia, projects and grant applications.
Katarzyna Kopanska, Project Manager
To join TEDD fill up the Application Form and send it to firstname.lastname@example.org. We will contact you.
If you have any questions do not hesitate to call us or send us an email (see contact details in the footer).
TEDD Partnership fee is effective from 2022 and is still at 40% off - CHF 450. In 2023 there will be a regular fee of CHF 750.
TEDD was established together with the introduction of 3D cell cultures technologies to a wider audience. Our goal is to support the development of these complex tissue systems and implement it into routine applications. In order to maximize the success, cooperation of partners with complementary skills –academia, industry (in particular biotechnology, pharmaceutical, medtech and cosmetics companies) and clinics is required. 3D cell culture became a widely acceptable and desirable technology, however, it did not yet reach its full potential. Therefore, further efforts should be made to maintain the progress of 3D cell technologies development. Our goal is to support the 3R principles implementation and the introduction of 3D cell culture technologies as the alternative for animal testing which can be used in your company.